Xiamen C&D has taken part in a $29.1m round for Jinda Nano Tech that will fuel the antibacterial product maker's research into nanotechnology.

Lundbeckfonden Ventures and Alexandria Venture Investments both backed a series A round for tumour and endocrine disease drug developer Tiburio.

Alexandria Venture Investments has taken part in the final close of the series B round, which will fund development of the company's cell therapy platform.

NetEase has invested $30m in the game studio that will be used to hire staff and develop a debut game that will be released in partnership with Marvel.

Martlet has reinvested in Exonate through a $1.8m funding round that increased the retinal eye drop maker's total funding to more than $11m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Silver Lake and Ontario Teachers’ Pension Plan backed a round that will fund acquisitions for Verily as well as the expansion of its strategic partnerships.

UCL spinout Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.

THC Ventures has led a $14.5m round that will fund Light Theto's R&D activities.

HTGF, Think.Health Ventures and Business Angels have also supplied funding to Max Planck Institute for Biochemistry mass spectrometry spinout PreOmics.